Fosfomycin/Tobramycin for Inhalation in Patients with Cystic Fibrosis with Pseudomonas Airway Infection

Rationale: Fosfomycin/tobramycin for inhalation (FTI), a unique, broad-spectrum antibiotic combination, may have therapeutic potential for patients with cystic fibrosis (CF). Objectives: To evaluate safety and efficacy of FTI (160/40 mg or 80/20 mg), administered twice daily for 28 days versus place...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Trapnell, Bruce C., McColley, Susanna A., Kissner, Dana G., Rolfe, Mark W., Rosen, Jonathan M., McKevitt, Matthew, Moorehead, Lisa, Montgomery, A. Bruce, Geller, David E.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Thoracic Society 2012
Soggetti:
Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3361752/
https://ncbi.nlm.nih.gov/pubmed/22095545
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.201105-0924OC
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi